Bellevue Asset Management (Switzerland)’s Nektar Therapeutics NKTR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2015 Q4	$3.64M	Sell	14,400 -1,600	-10%	-$404K	0.55%	58
2015 Q3	$2.65M	Buy	16,000 +2,667	+20%	+$442K	0.43%	72
2015 Q2	$2.5M	Buy	13,333 +5,600	+72%	+$1.05M	0.35%	77
2015 Q1	$1.28M	Buy	+7,733	New	+$1.28M	0.18%	111